rs2269475 — AIF1 AIF1 Arg69Trp

AIF1 Arg69Trp: A Macrophage Regulator in the Inflammatory Core

The AIF1 gene encodes allograft inflammatory factor 1¹¹ allograft inflammatory factor 1
also known as Iba1 (ionized calcium-binding adapter molecule 1), a calcium-binding actin-regulating protein expressed predominantly in macrophages and microglia. Sitting within the densely packed MHC class III region²² MHC class III region
the stretch of chromosome 6p21.3 containing dozens of immune-related genes between the class I and class II MHC loci alongside TNF and other inflammatory mediators, AIF1 plays a central role in macrophage activation and the control of chronic inflammation. The rs2269475 T allele introduces an Arg69Trp substitution that alters the protein's calcium-binding domain and has been associated with rheumatoid arthritis and systemic sclerosis.

The Mechanism

The rs2269475 C>T change replaces arginine (positively charged, hydrophilic) with tryptophan (bulky, hydrophobic) at position 69 of the AIF1 protein. Position 69 sits near the protein's EF-hand calcium-binding motif³³ EF-hand calcium-binding motif
a helix-loop-helix structural domain that coordinates calcium ions to regulate protein function, which AIF1 uses to modulate actin cytoskeleton dynamics in macrophages. When stimulated by interferon-gamma and pro-inflammatory cytokines, AIF1 promotes macrophage activation, drives secretion of IL-6, IL-10, IL-12, and TGF-β, and supports the proliferation of vascular smooth muscle cells and T-lymphocytes. The Arg69Trp substitution is predicted to alter local protein folding and potentially shift the protein's interaction with actin or calcium, though the precise functional consequence at the cellular level has not been fully characterized in published studies.

The Evidence

A 2008 case-control study of 276 Polish rheumatoid arthritis patients and 236 healthy controls found the TT genotype markedly over-represented in RA patients⁴⁴ the TT genotype markedly over-represented in RA patients
Pawlik A et al. "Association of allograft inflammatory factor-1 gene polymorphism with rheumatoid arthritis." Tissue Antigens 2008, with an odds ratio of 5.59 (95% CI: 1.22–25.55). The T allele frequency was 31.9% in RA patients versus 19.1% in controls (P=0.0003). Strikingly, T allele carriers with RA showed dramatically higher rates of anti-CCP antibody positivity (OR=8.82, 95% CI: 2.06–37.7), a hallmark of seropositive, erosive RA with higher long-term joint damage. No significant linkage disequilibrium was found with HLA-DRB1 shared epitope alleles, suggesting the AIF1 association may be independent of the classic MHC class II RA risk.

In systemic sclerosis, two independent studies found elevated T allele and CT/TT genotype frequencies in patients. Alkassab et al. 2007⁵⁵ Alkassab et al. 2007
"An AIF1 SNP is associated with anticentromere antibody positive systemic sclerosis." Rheumatology 2007 showed significant enrichment in ACA-positive patients across 1,015 SSc cases and 893 controls (OR ~1.5). Otieno et al. 2007⁶⁶ Otieno et al. 2007
"Allograft inflammatory factor-1 and tumor necrosis factor SNPs in systemic sclerosis." Tissue Antigens 2007 independently identified association with diffuse cutaneous SSc in 239 Caucasians (P=0.002) and strong linkage disequilibrium between the AIF1 risk allele and nearby TNF promoter variants — consistent with the region's coordinated inflammatory haplotype architecture.

In kidney transplant recipients, the T allele showed a paradoxical protective effect⁷⁷ the T allele showed a paradoxical protective effect
Vu D et al. "COX-2 and AIF-1 polymorphisms on allograft outcome in Hispanic kidney transplant recipients." Human Immunology 2013: CT/TT genotypes were associated with lower rejection risk (OR=0.63, P=0.038) in 527 Hispanic recipients. This likely reflects the immunological context-dependence of AIF1 signaling — macrophage activation that amplifies autoimmune responses in a native immune setting may paradoxically improve immunological tolerance in the allograft context.

Practical Implications

For carriers of the T allele — particularly TT homozygotes — the most actionable implication is heightened macrophage-driven inflammation in the context of autoimmune disease. The elevated anti-CCP association in RA suggests T allele carriers may be more likely to develop seropositive, erosive disease, making early and aggressive monitoring especially valuable. AIF1 is strongly expressed in the synovial tissue of RA patients, and its increased activity in macrophages drives IL-6 and TNF secretion that propagates joint inflammation.

The geographic proximity of AIF1 to TNF within the MHC class III region means T allele carriers may have inherited a broader inflammatory haplotype. This is relevant when interpreting other MHC-region results — particularly TNF -308 (rs1800629) and HLA-DRB1 shared epitope alleles.

Interactions

The AIF1 gene sits within 50 kb of the TNF gene cluster on chromosome 6p21.3. The rs2269475 risk allele is in strong linkage disequilibrium with rs4711274⁸⁸ strong linkage disequilibrium with rs4711274
an AIF1 5' region variant also associated with autoimmune phenotypes, and with specific TNFA promoter alleles including rs1800629⁹⁹ rs1800629
TNF -308 G>A, a major transcriptional regulator of TNF-alpha production. Carrying both the AIF1 rs2269475 T allele and the TNF -308 A allele may confer an additive inflammatory burden, though no published compound heterozygosity analysis has been performed for this specific combination. The rs2476601 PTPN22 variant (R620W) on chromosome 1 acts independently on T-cell signaling and is a separate major RA risk locus; carriers of both PTPN22 and AIF1 risk alleles may have cumulative autoimmune susceptibility.